Jay R. Luly is CEO & President at ENANTA PHARMACEUTICALS INC (ENTA). They have made 9 open-market trades across 1 company since 2014, most recently 2026-02-12.
CIK 0001571211
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $512K since 2025, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENTA | 871,871 | $9.7M |
Shares reported on the most recent Form 4, priced at the 2026-02-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTA | SELL | 2025-12-05 | 2025-12-05 | $14.23 | $135K | -3.6% | -5.9% | -7.0% |
| ENTA | BUY | 2025-02-12 | 2025-02-12 | $5.69 | $512K | +37.8% | +8.0% | -15.1% |
| ENTA | SELL | 2024-12-06 | 2024-12-10 | $8.06 | $41K | -26.5% | -40.5% | -20.8% |
| ENTA | SELL | 2023-12-05 | 2023-12-06 | $9.63 | $139K | -5.6% | +27.9% | +59.0% |
| ENTA | SELL | 2023-03-13 | 2023-03-14 | $45.16 | $2.5M | -9.9% | -15.8% | -42.6% |
| ENTA | SELL | 2022-12-16 | 2022-12-16 | $44.89 | $2.3M | +4.5% | +7.5% | -3.2% |
| ENTA | SELL | 2021-09-15 | 2021-09-17 | $59.06 | $533K | -2.5% | +19.5% | +25.4% |
| ENTA | SELL | 2018-07-05 | 2018-07-09 | $125.12 | $8.2M | -2.9% | -26.0% | -39.0% |
| ENTA | SELL | 2018-05-16 | 2018-05-18 | $105.82 | $5.3M | -4.5% | +9.1% | -14.4% |
| ENTA | SELL · 10b5-1 | 2015-03-09 | 2015-03-10 | $33.37 | $501K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-02-20 | 2015-02-20 | $35.35 | $530K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-01-05 | 2015-01-06 | $50.43 | $756K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-12-01 | 2014-12-02 | $45.38 | $681K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-11-03 | 2014-11-04 | $42.52 | $638K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-04-01 | 2014-04-02 | $39.17 | $588K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-03-10 | 2014-03-12 | $38.49 | $385K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-02-14 | 2014-02-14 | $38.10 | $221K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-01-02 | 2014-01-03 | $28.05 | $163K | -17.8% | +5.4% | +5.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.